期刊文献+

Preparation and immunogenicity of tag-free recombinant human eppin

Preparation and immunogenicity of tag-free recombinant human eppin
在线阅读 下载PDF
导出
摘要 Human epididymal protease inhibitor (eppin) may be effective as a male contraceptive vaccine. In a number of studies, eppin with an engineered His6-tag has been produced using prokaryotic expression systems. For production of pharmaceutical-grade proteins for human use, however, the His6-tag must be removed. This study describes a method for producing recombinant human eppin without a His6-tag. We constructed plasmid pET28a (+)-His6-tobacco etch virus (TEV)-eppin for expression in Escherichia coli. After purification and refolding, the fusion protein His6-TEV-eppin was digested with TEV protease to remove the His6-tag and was further purified by NTA-Ni2+ affinity chromatography. Using this procedure, 2 mg of eppin without a His6-tag was isolated from 1 I of culture with a purity of 〉95%. The immunogenicity of the eppin was characterized using male Balb/c mice. Human epididymal protease inhibitor (eppin) may be effective as a male contraceptive vaccine. In a number of studies, eppin with an engineered His6-tag has been produced using prokaryotic expression systems. For production of pharmaceutical-grade proteins for human use, however, the His6-tag must be removed. This study describes a method for producing recombinant human eppin without a His6-tag. We constructed plasmid pET28a (+)-His6-tobacco etch virus (TEV)-eppin for expression in Escherichia coli. After purification and refolding, the fusion protein His6-TEV-eppin was digested with TEV protease to remove the His6-tag and was further purified by NTA-Ni2+ affinity chromatography. Using this procedure, 2 mg of eppin without a His6-tag was isolated from 1 I of culture with a purity of 〉95%. The immunogenicity of the eppin was characterized using male Balb/c mice.
出处 《Asian Journal of Andrology》 SCIE CAS CSCD 2011年第6期889-894,共6页 亚洲男性学杂志(英文版)
基金 ACKNOWLEDGEMENTS The authors are grateful to Dr Zi-Chun Hua (The State Key Laboratory of Pharmaceutical Biotechnology and Department of Biochemistry, College of Life Science, Nanjing University, China) for kindly providing plasmid pET28a (+) and TEV endoprotease and to Dr Michael G. O'Rand (Laboratories for Reproductive Biology and Department of Cell and Developmental Biology, University of North Carolina at Chapel Hill, USA) for English-language editing. This study was supported by grants from the Key Project of the National Natural Science Foundation of China (No. 30930079) and the Chinese National Nature Science Foundation (No. 81001257).
关键词 Eppin IMMUNOGENICITY male contraception recombinant protein preparation tag-free Eppin immunogenicity male contraception recombinant protein preparation tag-free
  • 相关文献

参考文献1

共引文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部